| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_397384a6d230e34cf9e18e9c7d9b0a03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d33087dfb06f23a561b692aecc073feb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_903d752faffe9be72232d57a6fb909c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe916a083a071eb2f4617fcd1d6d449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a6798fb27c67b9eb2013f79865f732f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54cbff577b586de252e2f53e6b85c5e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2496e1af6b6770fe11f4e494c84de93c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25b0c145fee92b0e07b033ec30a4820e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48afc53ef8a06b0dd8f68c32abab63d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c9d4c64ba4efe4b6855c7fd2a7ada9d |
| publicationDate |
2019-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3427723-A1 |
| titleOfInvention |
Rna formulation for immunotherapy |
| abstract |
The present invention is in the field of immunotherapy, in particular tumor immunotherapy. The present invention provides pharmaceutical formulations for delivering RNA to antigen presenting cells such as dendrite cells (DCs) in the spleen after systemic administration. In particular, the formulations described herein enable to induce an immune response after systemic administration of antigen-coding RNA. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020200472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020201383-A1 |
| priorityDate |
2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |